Four-Month Rifapentine Regimens with or without Moxifloxacin for TuberculosisSusan E. Dorman, Richard E. Chaisson, Samuel Pierre et al.|New England Journal of Medicine|2021Cited by 548
Association between Acquired Rifamycin Resistance and the Pharmacokinetics of Rifabutin and Isoniazid among Patients with HIV and TuberculosisMarc Weiner, Thomas Hodge, Debra Benator et al.|Clinical Infectious Diseases|2005Cited by 227
Low Isoniazid Concentrations and Outcome of Tuberculosis Treatment with Once-Weekly Isoniazid and RifapentineMarc Weiner, Thomas Hodge, William J. Burman et al.|American Journal of Respiratory and Critical Care Medicine|2003Cited by 193
Effects of Tuberculosis, Race, and Human Gene <i>SLCO1B1</i> Polymorphisms on Rifampin ConcentrationsMarc Weiner, Andrew Vernon, Charles A. Peloquin et al.|Antimicrobial Agents and Chemotherapy|2010Cited by 156
Acquired Rifamycin Resistance with Twice-Weekly Treatment of HIV-related TuberculosisWilliam J. Burman, Wafaa El‐Sadr, Debra Benator et al.|American Journal of Respiratory and Critical Care Medicine|2005Cited by 155